Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beam Therapeutics (BEAM) Tax Provisions (2022 - 2024)

Historic Tax Provisions for Beam Therapeutics (BEAM) over the last 3 years, with Q4 2024 value amounting to $61000.0.

  • Beam Therapeutics' Tax Provisions fell 9564.29% to $61000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was $61000.0, marking a year-over-year decrease of 9576.09%. This contributed to the annual value of $100000.0 for FY2024, which is 9285.71% down from last year.
  • As of Q4 2024, Beam Therapeutics' Tax Provisions stood at $61000.0, which was down 9564.29% from $39000.0 recorded in Q2 2024.
  • In the past 5 years, Beam Therapeutics' Tax Provisions ranged from a high of $2.4 million in Q3 2022 and a low of $39000.0 during Q2 2024
  • For the 3-year period, Beam Therapeutics' Tax Provisions averaged around $982000.0, with its median value being $1.0 million (2022).
  • Per our database at Business Quant, Beam Therapeutics' Tax Provisions skyrocketed by 4000.0% in 2023 and then plummeted by 9564.29% in 2024.
  • Over the past 3 years, Beam Therapeutics' Tax Provisions (Quarter) stood at $1.0 million in 2022, then soared by 40.0% to $1.4 million in 2023, then tumbled by 95.64% to $61000.0 in 2024.
  • Its Tax Provisions stands at $61000.0 for Q4 2024, versus $39000.0 for Q2 2024 and $1.4 million for Q4 2023.